Percutaneous osteoplasty as a treatment for painful malignant bone lesions of the pelvis and femur.
The purposes of this report are to describe percutaneous osteoplasty as a highly effective minimally invasive procedure to treat painful malignant bone lesions of the pelvis, ilium, and femur and to discuss the relevant literature. Five patients with histologically proven metastases to the pelvis, ilium, or femur were treated by percutaneous injection of liquid bone cement as an attempt to control severe bone pain. After percutaneous osteoplasty, all five patients experienced immediate and substantial pain relief and did not require pain medication for the duration of follow-up. No clinically significant complications occurred. Whereas percutaneous osteoplasty of the spine (vertebroplasty) is well-described and widely accepted to treat pain caused by benign or malignant vertebral body diseases, osteoplasty of bones outside the spine is less known. The immediate good clinical results observed in our small patient group should encourage more widespread application of this palliative treatment.
Hierholzer
Johannes
J
Department of Diagnostic and Interventional Radiology, Klinikum Ernst von Bergmann, Potsdam, Germany. jhierholzer@klinikumevb.de
Anselmetti
Gianni
G
Fuchs
Heiko
H
Depriester
Claude
C
Koch
Karin
K
Pappert
Dirk
D
D000368:Aged; D016587:Antimutagenic Agents / Q000627:therapeutic use; D001843:Bone Cements / Q000627:therapeutic use; D003287:Contrast Media; D005260:Female; D005266:Femoral Neoplasms / Q000175:diagnosis / Q000601:surgery*; D005269:Femur / Q000000981:diagnostic imaging / Q000601:surgery; D005471:Fluoroscopy; D006801:Humans; D008297:Male; D020366:Methylmethacrylate / Q000627:therapeutic use; D008875:Middle Aged; D019637:Orthopedic Procedures; D010146:Pain / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery*; D010386:Pelvic Neoplasms / Q000175:diagnosis / Q000601:surgery*; D010388:Pelvis / Q000000981:diagnostic imaging / Q000601:surgery; D011126:Polypropylenes / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D016587:Antimutagenic Agents; D001843:Bone Cements; D003287:Contrast Media; D011126:Polypropylenes; D020366:Methylmethacrylate